Home > Healthcare > Analytical Instruments > Immunoassay > Immunoassay Market

Immunoassay Market Trends

Report ID: GMI8041
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Immunoassay Market Trends

Advancements in immunoassay technologies play a significant role as driver for the market as it influences various aspects of molecular diagnostics, research applications, accurate monitoring of diseases, and the overall healthcare landscape.

For instance, according to a report of the National Library of Medicines, in 2023, single-molecule immunoassay technique can test 66 samples in 1 hour, making more efficient than conventional immunological detection techniques.
Furthermore, advancements in immunoassay technologies have facilitated the integration of multiplexing capabilities, enabling the simultaneous detection of multiple biomarkers in a single test. Consequently, providing a comprehensive and efficient approach to assessing complex diseases, contributing to a more holistic understanding of patient health.
Thus, the continuous evolution of new technologies by addressing key challenges, expanding application areas, boost the market size.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global immunoassay industry was valued at USD 31.4 billion in 2023 and is estimated to grow at a CAGR of 5.3% between 2024 and 2032, as they help in the diagnosis, monitoring, and management of chronic conditions due to their ability to detect specific biomarkers associated with these diseases.

The reagents & kits segment held the largest market share of 66.2% in 2023 and will continue gain traction as they are essential for conducting immunoassay procedures.

In 2023, North America held a significant share of 40.6% in the global immunoassay market, attributed to highly advanced and well-established healthcare infrastructure.

Abbott Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Sysmex Corporation, Becton Dickinson and Company, QIAGEN, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Danaher Corporation, Luminex Corporation, F. Hoffmann-La Roche AG and Hologic Inc.